KRAS and colorectal carcinoma: The test was optimized using single-stranded synthetic DNA targets and cell lines expressing the wild-type and the mutated (G12D) KRAS gene and also allowed for the detection of three different KRAS mutations in FFPE tissue samples from CRC patients.